RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 2010; 103(02): 469-471
DOI: 10.1160/TH09-10-0679
DOI: 10.1160/TH09-10-0679
Letters to the Editor
Endogenous thrombin potential, prothrombin fragment 1+2 and D-dimers during pregnancy
Weitere Informationen
Publikationsverlauf
Received:
01. Oktober 2009
Accepted after minor revision:
24. Oktober 2009
Publikationsdatum:
22. November 2017 (online)
-
References
- 1 Holmes VA, Walalce JMW. Haemostasis in normal pregnancy: a balancing act?. Biochem Soc Trans 2005; 33: 428-432.
- 2 Zöller B, Holm J, Svensson P. et al. Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency. Thromb Haemost 1996; 75: 270-274.
- 3 Eichinger S, Weltermann A, Philipp K. et al. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden. Thromb Haemost 1999; 82: 1232-1236.
- 4 Kjellberg U, Andersson NE, Rosen S. et al. APC reisistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 1999; 81: 527-531.
- 5 Bombeli T, Raddatz-Mueller P, Fehr J. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women. Am J Obstet Gynecol 2001; 184: 382-389.
- 6 Curvers J, Thomassen MC, Rimmer J. et al. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test. Thromb Haemost 2002; 88: 5-11.
- 7 Rosenkranz A, Hiden M, Leschnik B. et al. Calibrated automated thrombin generation in normal uncomplicated pregnancy. Thromb Haemost 2008; 99: 331-337.
- 8 Dargaud Y, Trzeciak MC, Bordet JC. et al. Use of calibrated automated thrombinography +/- thrombomodulin to recognise the prothrombotic pheno-type. J Thromb Haemost 2006; 6: 562-567.
- 9 Hemker HC, Giesen P, Al Dieri R. et al. Calibarated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
- 10 Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003; 16: 153-168.
- 11 Arkel YS, Paidas MJ, Ku DH. The use of coagulation activation markers (soluble fibrin polymer, prothrombin fragment 1.2, thrombin-antithrombin, and D dimer) in the assessment of hypercoagulability in patients with inherited and acquired prothrombotic disorders. Blood Coagul Fibrinolysis 2002; 13: 199-205.
- 12 Greenberg CS, Hursting MJ, Macik BG. et al. Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2. Clin Chem 1994; 40: 1962-1969.
- 13 Astermark J, Tengborn L, Hedner U. et al. Anti- and procoagulant activities in factor VII-deficient subjects. Thromb Res 2001; 101: 435-440.
- 14 Kulkarni AA, Lee CA, Kadir RA. Pregnancy in women with congenital factor VII deficiency. Haemophilia 2006; 12: 413-416.
- 15 Kline JA, Williams GW, Hernandez-Nino J. D-Dimer Concentrations in Normal Pregnancy: New Diagnostic Thresholds Are Needed. Clin Chem 2005; 51: 825-829.
- 16 Blanco-Molina A, Trujillo-Santos J, Criado J. et al., for the RIETE Investigators. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry. Thromb Haemost 2007; 97: 186-190.